The variability of functional MRI brain signal increases in Alzheimer's disease at cardiorespiratory frequencies

Abstract Biomarkers sensitive to prodromal or early pathophysiological changes in Alzheimer’s disease (AD) symptoms could improve disease detection and enable timely interventions. Changes in brain hemodynamics may be associated with the main clinical AD symptoms. To test this possibility, we measur...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Timo Tuovinen, Janne Kananen, Zalan Rajna, Johannes Lieslehto, Vesa Korhonen, Riikka Rytty, Heli Mattila, Niko Huotari, Lauri Raitamaa, Heta Helakari, Ahmed Abou Elseoud, Johanna Krüger, Pierre LeVan, Osmo Tervonen, Juergen Hennig, Anne M. Remes, Maiken Nedergaard, Vesa Kiviniemi
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/caee84f1ec8b4f068b3915608e8cac85
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Abstract Biomarkers sensitive to prodromal or early pathophysiological changes in Alzheimer’s disease (AD) symptoms could improve disease detection and enable timely interventions. Changes in brain hemodynamics may be associated with the main clinical AD symptoms. To test this possibility, we measured the variability of blood oxygen level-dependent (BOLD) signal in individuals from three independent datasets (totaling 80 AD patients and 90 controls). We detected a replicable increase in brain BOLD signal variability in the AD populations, which constituted a robust biomarker for clearly differentiating AD cases from controls. Fast BOLD scans showed that the elevated BOLD signal variability in AD arises mainly from cardiovascular brain pulsations. Manifesting in abnormal cerebral perfusion and cerebrospinal fluid convection, present observation presents a mechanism explaining earlier observations of impaired glymphatic clearance associated with AD in humans.